Marlpits Lane, Honiton, Devon, EX14 2NY

Tel: 01404 548 544

Contact Details and Opening Times



Medical research has been conducted at the Honiton Surgery for over 20 years. We have a small research team led by Dr Danny Murphy.

The team receive details of research studies approved by the NHS and decide which studies are feasible and appropriate to be carried out at Honiton. These studies cover all aspects of health care including diabetes care, early diagnosis of cancer, assessing dressings and wound care, post flu vaccine surveillance and assessment of new medicines.

All the studies have been assessed by the NHS and have full ethical approval. The surgery receives funding for research from the South West Peninsula Clinical Research Network (part of the NHS) and from the individual studies that we take part in. The research team undergo regular training in taking informed consent from patients taking part in studies and the surgery has Royal College of GPs Research Ready accreditation.

The surgery research team assess study design, discuss practical issues of running a study at the surgery and liaise with the Patient Participation team at the Clinical Research Network.

The surgery believes that medical research is important for many reasons. Research studies help to answer specific questions about health and health care. The design of a study reflects the question(s) that it is seeking to answer. For example, studies can explore:

  • Whether or not new treatments or ways of organising services are effective (do they work?)
  • Whether or not those treatments or services are cost-effective (do they give value for money?)
  • how different health problems develop and progress over time
  • the views of patients and health professionals about a particular treatment, intervention or service and how they might be improved

For further information about research at the surgery please see below.

Current Research Trials & Studies


We're excited to share news of our partnership with seasoned NIHR CRN (National Institute for Health Research Clinical Research Network) experts, seamlessly integrated into our practice team. In the pursuit of advancing medical research, these professionals, alongside our practice team, may access your patient record for pre-consented activities. This involves identifying potential eligibility for research opportunities and supporting recruitment and follow-up for clinical trials. This process operates under the lawful bases of Article 6 (public task) and Article 9 (substantial public interest) of the GDPR. Be assured, that your privacy and data security are rigorously safeguarded. This collaboration also supports NIHR and NHS's pursuit in improving equality to access research. Any eligible individuals will be contacted by the practice, and their consent will be requested before any further processing takes place. 


The RELIEF trial is looking at whether a combined inhaler is better for treating mild asthma symptoms. Approximately 10% of UK adults have 'mild' asthma symptoms requiring a reliever (blue inhaler) for symptoms with or without a low dose-inhaled steroid treatment. The Global initiative for Asthma (world wide recommendations) suggest replacing the first choice standard blue inhaler for asthma patients with a combination inhaler containing both reliever and preventer medicine. So the study aims to determine:

  • How effective a combination inhaler might be versus standard care for symptom relief in mild asthma
  • Overall costs and savings of the two treatments
  • Healthcare providers and patients views of the new way to treat mild asthma

We will be sending texts and emails out to patients who may fall into the category of 'mild' asthma to ask if they may be interested in taking part. This is completely a patient choice and will not affect your ongoing care in anyway if you decline. If you are interested to take part just respond 'Yes' to the questionnaire we send out and our Research Nurse will follow up with you in late May / June. If we have a large number of people responding we may need to choose a selection of patients interested at random.

Further information can be found here and a video can be found here


Volunteers needed for research into a new medicine to treat obesity.

Researchers at Royal Devon University Healthcare NHS Foundation Trust are trialling a new medicine that may treat obesity while also improving diseases of the heart and blood vessels – and volunteers are needed. The study is being delivered by the National Institute for Health and Care Research (NIHR) Patient Recruitment Centre (PRC): Exeter, which is hosted by the RDUH Hospital.

The study, REDEFINE 3, is looking at a combination of two medicines called cagrilinitide and semaglutide (CagriSema), which have been shown in previous clinical trials to help people lose weight. REDEFINE 3 is needed to help us understand how effective CagriSema is for reducing cardiovascular events, such as heart attacks and stroke.

You may be eligible to take part in the study if:

• You have had a stroke, a heart attack (myocardial infarction), or have poor circulation (peripheral arterial disease, or PAD)

• You are 55 years of age or older

• You are living with obesity (BMI over 25)

For more information, visit the study website or contact our study team:  01392 406289


The Victorion-1 PREVENT study will assess if an investigational medication can prevent cardiovascular events (such as heart attacks, strokes, procedures to improve blood flow, and death) in the future by lowering LDL cholesterol in the blood. People may be eleigible for this study if:

Aged 40 - 79yrs of age, have high LDL cholesterol levels, have not experienced a major cardiovascular event and are at high risk for a major cardiovascular event in the future.

We will be sending texts out to patients who MAY be eligible to see if they are interesting in joining the study. More information can be found from calling 01392 406289 or emailing 


This is a study starting March 2024. BEACON is an online clinical trial for people with Long Covid who are experiencing brain fog or having problems with their memory and brain health. It aims to test a brain training app in people aged 18 and over and will last six months. People can take part from home by registering for the trial on their smartphone, device or computer. BEACON will involve over 1500 people across the UK. 

We are will be sending out text messages so people can join IF THEY WISH TO that read as follows:

Are you experiencing brain fog or memory problems after having Covid-19? The new BEACON research trial is testing a brain training app to improve brain health. If you are interested the research team are recruiting now at 

What happens if you join? After clicking the link, reading an information sheet and giving consent to take part, you will be asked to complete a set of questionnaires and brain tests on your computer or device. You will then be randomly allocated to one of two groups and will have access to six brain training games. You can log in and play the games as often as you like. The research team recommend playing at least three times a week for ten minutes.  

By taking part you will be joining a national community of people with Long Covid who are contributing to vital research into brain health and Covid-19. 

RSC Virology Swabs

If you or a member of your family have had a flu-like illness or a respiratory infection within the last 10 days you may be able to help monitor the spread of respiratory viruses. 

Every year, there are a range of respiratory viruses circulating across communities. The Oxford-Royal College of General Practitioners (RCGP) Research & Surveillance Centre (RSC) have been monitoring the spread of the respiratory viruses with swabs for over 50 years, tracking new viruses as they appear. We look at the spread of respiratory viruses across the country every week to inform public health policy and use the information to help understand the effectiveness of vaccines against those viruses. Please see the RSC's Patient Virology Poster for more information.

PRINCIPLE Research Study

The PRINCIPLE trial aims to find treatments that reduce hospital admission and improve symptoms for people with COVID-19. You could be eligible to join if:

  • You are experiencing COVID-19 symptoms for 14 days or less
  • AND: You have had a positive test for COVID-19 in the last 14 days
  • AND: You are aged 18 or over

Please see the PRINCIPLE Research Study website to find out more.

Please call the Trial Team if you have any questions or do not have access to online systems: 0800 138 0880

Duration Trial

A trial to find out the shortest time someone can have an antibiotic when they have a UTI (Urinary Tract Infection) and still treat that condition effectively. People who are over 18yrs and present to the GP with UTI symptoms may be eligible to be part of the study. More information can be found on the  trial study website